JYLAMVO
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for JYLAMVO, covering 2022-11-29 to 2024-10-24. Get the full timeline:
Most recent: EMA Authorised: Jylamvo (methotrexate) — Oresund Pharma ApS
3 regulatory and trial events tracked for JYLAMVO, covering 2022-11-29 to 2024-10-24. Get the full timeline:
Most recent: EMA Authorised: Jylamvo (methotrexate) — Oresund Pharma ApS